• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A primary signet ring cell carcinoma of the prostate with bone metastasis with impressive response to FOLFOX and cetuximab.

作者信息

Roldán Ana Milena, Núñez Natalia Fernández, Grande Enrique, García Augusto Álvarez, Antón-Aparicio Luis M

机构信息

Clinical Oncology Department, A Coruña University Hospital, A Coruña, Spain.

出版信息

Clin Genitourin Cancer. 2012 Sep;10(3):199-201. doi: 10.1016/j.clgc.2012.01.006. Epub 2012 Mar 10.

DOI:10.1016/j.clgc.2012.01.006
PMID:22409863
Abstract
摘要

相似文献

1
A primary signet ring cell carcinoma of the prostate with bone metastasis with impressive response to FOLFOX and cetuximab.一例前列腺原发性印戒细胞癌伴骨转移，对FOLFOX和西妥昔单抗治疗反应显著。
Clin Genitourin Cancer. 2012 Sep;10(3):199-201. doi: 10.1016/j.clgc.2012.01.006. Epub 2012 Mar 10.
2
A case with cardiac tamponade as the first sign of primary gastric signet-ring cell carcinoma treated with combination therapy.以心脏压塞为首发表现的原发性胃印戒细胞癌 1 例，采用联合治疗。
Med Sci Monit. 2010 Apr;16(4):CS41-44.
3
Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer.氟尿嘧啶、亚叶酸钙以及奥沙利铂联合或不联合西妥昔单抗用于转移性结直肠癌的一线治疗。
J Clin Oncol. 2009 Feb 10;27(5):663-71. doi: 10.1200/JCO.2008.20.8397. Epub 2008 Dec 29.
4
[A case of anal canal carcinoma with systemic lymph node metastases successfully treated by bevacizumab+mFOLFOX6 therapy].
Gan To Kagaku Ryoho. 2009 Nov;36(12):2229-31.
5
Best cases from the AFIP: urachal carcinoma.武装部队病理研究所的最佳病例：脐尿管癌。
Radiographics. 2009 May-Jun;29(3):939-42. doi: 10.1148/rg.293085152.
6
N0147: a randomized phase III trial of oxaliplatin plus 5-fluorouracil/leucovorin with or without cetuximab after curative resection of stage III colon cancer.N0147：一项关于奥沙利铂联合5-氟尿嘧啶/亚叶酸钙，在III期结肠癌根治性切除术后加用或不加用西妥昔单抗的随机III期试验。
Clin Colorectal Cancer. 2005 Sep;5(3):211-3. doi: 10.3816/ccc.2005.n.033.
7
Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer.西妥昔单抗联合氟尿嘧啶、亚叶酸钙和奥沙利铂用于转移性结直肠癌一线治疗的II期试验。
J Clin Oncol. 2007 Nov 20;25(33):5225-32. doi: 10.1200/JCO.2007.13.2183.
8
Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German setting.在德国环境下，针对 K-ras 野生型结直肠癌患者肝内初始不可切除转移的靶向治疗药物西妥昔单抗的成本效益分析。
Clin Ther. 2011 Apr;33(4):482-97. doi: 10.1016/j.clinthera.2011.04.010.
9
Effectiveness and safe use of modified FOLFOX-6 for metastatic gastric cancer with signet ring cell components complicated by disseminated intravascular coagulation and diffuse bone marrow carcinomatosis.改良FOLFOX-6方案用于伴有印戒细胞成分的转移性胃癌合并弥散性血管内凝血及弥漫性骨髓转移癌的有效性及安全性
Onkologie. 2012;35(3):118-20. doi: 10.1159/000336971. Epub 2012 Feb 20.
10
Detection of KRAS oncogene in peripheral blood as a predictor of the response to cetuximab plus chemotherapy in patients with metastatic colorectal cancer.检测外周血中KRAS癌基因作为转移性结直肠癌患者对西妥昔单抗联合化疗反应的预测指标。
Clin Cancer Res. 2009 Jul 1;15(13):4508-13. doi: 10.1158/1078-0432.CCR-08-3179. Epub 2009 Jun 23.

引用本文的文献

1
Prostate Adenocarcinoma with Signet-Ring Cells and Features of Mucin: A Clinical Case and Literature Review.前列腺腺癌伴印戒细胞和黏液特征：临床病例与文献复习。
Medicina (Kaunas). 2024 May 27;60(6):877. doi: 10.3390/medicina60060877.
2
A Case of Prostatic Signet-Ring Cell-like Carcinoma with Pagetoid Spread and Intraductal Carcinoma and Long-Term Survival: PD-L1 and Mismatch Repair System Proteins (MMR) Immunohistochemical Evaluation with Systematic Literature Review.1例伴有派杰样播散和导管内癌的前列腺印戒细胞样癌及长期生存：PD-L1和错配修复系统蛋白（MMR）免疫组化评估及系统文献综述
J Pers Med. 2023 Jun 19;13(6):1016. doi: 10.3390/jpm13061016.
3
Diagnosis and Management of Primary Prostatic Signet Ring Cell Carcinoma: Single-Center Experience.
原发性前列腺印戒细胞癌的诊断和治疗：单中心经验。
Am J Mens Health. 2022 Mar-Apr;16(2):15579883221087839. doi: 10.1177/15579883221087839.
4
Immunohistochemical analysis of PD-L1 and tumor-infiltrating immune cells expression in the tumor microenvironment of primary signet ring cell carcinoma of the prostate.前列腺原发性印戒细胞癌肿瘤微环境中 PD-L1 和肿瘤浸润免疫细胞表达的免疫组织化学分析。
Asian J Androl. 2022 Sep-Oct;24(5):525-532. doi: 10.4103/aja202186.
5
Primary Signet Ring Cell Carcinoma of the Prostate: A Rare Case Report.原发性前列腺印戒细胞癌：1例罕见病例报告
J Clin Med. 2018 Aug 15;7(8):218. doi: 10.3390/jcm7080218.
6
Primary signet ring cell carcinoma of the prostate treated by radical cystoprostatectomy and chemoradiotherapy.经根治性膀胱前列腺切除术及放化疗治疗的原发性前列腺印戒细胞癌
Can Urol Assoc J. 2016 May-Jun;10(5-6):E204-E206. doi: 10.5489/cuaj.3122. Epub 2016 May 12.